Who are Quadrivalent seasonal influenza vaccine GSK2282512A's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Seasonal trivalent vaccine, trivalent seasonal influenza vaccine, High Dose Trivalent Influenza Vaccine, HD-TIV, Fluvirin(TIVf), SP Shz TIV.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/quadrivalent-seasonal-influenza-vaccine-gsk2282512a.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Quadrivalent seasonal influenza vaccine GSK2282512A — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quadrivalent seasonal influenza vaccine GSK2282512A (Quadrivalent seasonal influenza vaccine GSK2282512A) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: influenza vaccine. Area: Immunology.

phase 3 influenza vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Quadrivalent seasonal influenza vaccine GSK2282512A (Quadrivalent seasonal influenza vaccine GSK2282512A) — GlaxoSmithKline. This vaccine stimulates the body's immune system to produce antibodies against four different influenza viruses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Quadrivalent seasonal influenza vaccine GSK2282512A TARGET	Quadrivalent seasonal influenza vaccine GSK2282512A	GlaxoSmithKline	phase 3	influenza vaccine
Seasonal trivalent vaccine	Seasonal trivalent vaccine	Sinovac Biotech Co., Ltd	marketed	Inactivated influenza vaccine
trivalent seasonal influenza vaccine	trivalent seasonal influenza vaccine	Sinovac Biotech Co., Ltd	marketed	inactivated influenza vaccine
High Dose Trivalent Influenza Vaccine	High Dose Trivalent Influenza Vaccine	Brigham and Women's Hospital	marketed	Inactivated influenza vaccine
HD-TIV	HD-TIV	McGill University Health Centre/Research Institute of the McGill University Health Centre	marketed	Inactivated influenza vaccine
Fluvirin(TIVf)	Fluvirin(TIVf)	Novartis	marketed	Inactivated influenza vaccine
SP Shz TIV	SP Shz TIV	Sanofi	marketed	Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (influenza vaccine class)

GlaxoSmithKline · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quadrivalent seasonal influenza vaccine GSK2282512A — Competitive Intelligence Brief. https://druglandscape.com/ci/quadrivalent-seasonal-influenza-vaccine-gsk2282512a. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab